A Case Report Demonstrating the Potential Clinical Relevance of Liquid Tumor Biopsies in Lung Cancer

A 50-year-old male with advanced non-small-cell lung cancer was unable to have standard-of-care molecular testing performed at diagnosis as a result of inadequacy of the available tissue. A subsequently performed commercial liquid tumor biopsy (Foundation ACT®) revealed an epidermal growth factor re...

Full description

Bibliographic Details
Main Authors: Revathi Suppiah, Bruce Gershenhorn, Maurie Markman
Format: Article
Language:English
Published: Karger Publishers 2016-11-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/450700